Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)
Status:
Terminated
Trial end date:
2012-12-13
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the suitability of the challenge model in measuring the
efficacy of MEDI-557 compared to placebo in healthy adult participants for the reduction in
the incidence of RSV through 12 days post-RSV challenge with the RSV Memphis-37 strain.